Results 61 to 70 of about 28,588 (290)
ABSTRACT Background and Aims Polycystic ovarian syndrome, with a mean incidence of 5–10, is the most common endocrine disorder affecting women of reproductive age. These patients suffer from a wide range of symptoms that are inversely related to their resilience and quality of life.
Soghra Khani +4 more
wiley +1 more source
High order multiple births in the Maltese population [PDF]
Triplets are a relatively rare occurrence being encountered in the Maltese Islands with an overall incidence of about 0.1 per 1000 maternities. The incidence appears to be on the increase over the last twenty years rising from the 0.08 per 1000 ...
Savona-Ventura, Charles, Zammit, Anthony
core
Gynecologic surgery for benign disease: Preserving reproductive potential
Abstract Preserving fertility is essential when managing benign gynecologic disorders in reproductive‐aged women. Surgical interventions can impact future fertility, therefore requiring an evidence‐based, individualized approach. The FIGO Committee on Reproductive Endocrinology and Infertility reviewed current literature to develop recommendations for ...
Togas Tulandi +23 more
wiley +1 more source
Comparison of the efficiency of clomiphene citrate and letrozole in combination with metformin in moderately obese clomiphene citrate - resistant polycystic ovarian syndrome patients [PDF]
Introduction. Polycystic ovary syndrome is the most common endocrinopathy in women of reproductiveage. Therapy for those who want to get pregnant involves ovulation induction using clomiphene citrate, metformin, letrozole and gonadotropins ...
Bjelica Artur +4 more
doaj +1 more source
Ovarian Aging: Mechanisms, Age‐Related Disorders, and Therapeutic Interventions
A comprehensive overview of the molecular mechanisms underlying ovarian aging, its association with age‐related diseases, and potential therapeutic interventions. Ovarian aging involves DNA damage, mitochondrial dysfunction, oxidative stress, telomere attrition, and follicular depletion, driving age‐related infertility, menopause, and multiple systemic
Xingyu Liu +4 more
wiley +1 more source
Letrozole is widely known for its use as an ovulation inductor. This study aims to investigate the effects of letrozole and clomiphene citrate in females with polycystic ovarian syndrome.
M. Al-Obaidi +4 more
semanticscholar +1 more source
Testosterone Replacement, Where Are We in 2025?
ABSTRACT Testosterone replacement therapy has evolved significantly in recent years, driven by high‐quality clinical evidence and expanded treatment options. The 2023 TRAVERSE trial provided definitive cardiovascular safety data, leading to FDA removal of black box warnings in 2025 and altering the clinical approach to testosterone therapy.
Arnaav Walia +8 more
wiley +1 more source
The position of diagnostic laparoscopy in current fertility practice [PDF]
In everyday clinical practice, it is not always clear if and when exactly in the fertility work-up a diagnostic laparoscopy should be offered. The aim of this review is to analyse the available evidence with respect to alternative diagnostic methods for ...
Bosteels, Jan +3 more
core +1 more source
ABSTRACT The study by Morshed‐Behbahani et al. highlights that financial barriers are not the sole obstacle to accessing infertility treatment. To ensure equal access for all, infertility treatment should be regarded as a universal human right, with the public sector assuming responsibility for its provision.
Arturs Kalva, Girts Brigis
wiley +1 more source
BackgroundTo determine whether progestin-primed ovarian stimulation (PPOS) is more effective for women with diminished ovarian reserve (DOR) than clomiphene citrate (CC)/letrozole (LE) plus gonadotropin in IVF or ICSI treatment.MethodsNine databases were
Guangyao Lin +4 more
doaj +1 more source

